Lens Epithelium Derived Growth Factor/p75 (LEDGF/p75) is a prominent cellular interaction partner of HIV-1 integrase, tethering the preintegration complex to the host chromosome. In light of the development of LEDGF/p75-integrase interaction inhibitors it is essential to understand the cell biology of LEDGF/p75. We identified pogZ as new cellular interaction partner of LEDGF/p75. Alike lentiviral integrases pogZ, a domesticated transposase, carries a DDE domain, the major determinant for LEDGF/p75 interaction. Using different in vitro and in vivo approaches we corroborated the interaction between the C-terminus of LEDGF/p75 and the DDE domain of pogZ revealing an overlap in the binding of pogZ and HIV-1 IN. Competition experiments showed that integrase is efficient in displacing pogZ from LEDGF/p75. Moreover, pogZ does not seem to play a role as a restriction factor of HIV. The finding that LEDGF/p75 is capable of interacting with a DDE domain protein that is not a lentiviral integrase, points to a profound role of LEDGF/p75 in DDE domain protein function.
Introduction
In 2003 we identified LEDGF/p75 as the major cellular interaction partner of HIV-1 integrase (IN) (1) . In vitro studies demonstrated that the interaction of LEDGF/p75 is restricted to lentiviral integrases (2) (3) (4) . In recent years the important role of LEDGF/p75 in HIV replication has been demonstrated. Knock-down (5,6), knock-out (7) and transdominant inhibition studies (6, 8, 9) all revealed a pivotal role of LEDGF/p75 in HIV-1 integration and replication. These studies also provided a proofof-principle to block the interaction between LEDGF/p75 and HIV-1 IN as a potential antiviral strategy. By sequencing lentiviral vector integration sites in mouse LEDGF/p75 knock-out cell lines (7) and human LEDGF/p75 knockdown cell lines (10, 11) , the co-factor was shown to play a role in integration site selection. Indeed, depletion of LEDGF/p75 induced a shift in lentiviral integration sites from the characteristic distribution in transcription units (TUs) outside the promoter regions to a more random distribution. The interaction between LEDGF/p75 and HIV-1 IN is mediated by the IN binding domain (IBD) in the C-terminus of LEDGF/p75 (12) . A crystal structure of a complex between two IBDs and a dimer of HIV-1 IN catalytic core domains (CCDs), identified amino acid residues in LEDGF/p75 that are essential for the interaction with IN (13) . The hydrophobic amino acids I365, F406 and V408 and the charged D366 residue, all reside in the interhelical loops of the IBD. As a ubiquitously expressed protein, LEDGF/p75 functions as a transcriptional co-activator protecting cells from extracellular stress by regulating transcription of stress-related genes (for a review see: (14) ). By preventing cells from undergoing apoptotic cell death the protein is also involved in oncogenesis (15) (16) (17) (18) (19) . Through a link with the MLL (mixed-lineage leukemia) histone methyltransferase, LEDGF/p75 was recently shown to be essential for MLLdependent transcription and leukemic transformation (20) . To gain more insight into the cellular and virological role of LEDGF/p75, we attempt to identify and validate the cellular interaction partners of LEDGF/p75. Previously, we and others identified JPO2 as a first cellular interaction partner of the C-terminal end of LEDGF/p75 (21, 22) . Like HIV-1 IN, JPO2 also interacts with the IBD of LEDGF/p75. Amino acid residues in the IBD that are critical for IN interaction were not crucial for the interaction with JPO2 (21) pointing to differential structural constraints for both interactions.
Here we describe the identification of the interaction between the cellular protein pogZ (pogo transposable element derived protein with zinc finger) and the C-terminus of LEDGF/p75 using yeast-two-hybrid screening. Our in silico analysis of the protein sequence indicates that pogZ represents a domesticated transposase related to the Tigger Derived (TIGD) DNAtransposases with a DDE domain (23). A DDE domain, also present in lentiviral integrases (24) , is characterized by a catalytic site composed of two or three aspartic acid and/or glutamic acid residues with a specific spatial arrangement to allow coordination of Mg 2+ cations (25) . It allows DNA modifying reactions such as strand cleaving, nicking and ligation. Our characterization of the interaction between pogZ and LEDGF/p75 gives new insight in the role of LEDGF/p75 and suggest a more profound role for LEDGF/p75 in DDE domain protein function. They support speculation on a possible evolutionary relationship between DNA transposons and lentiviral integrases.
Experimental Procedures
Yeast-two-hybrid. A yeast two-hybrid screen was performed using a cell-to-cell mating protocol (26) . The experimental set-up was designed as described previously (27) . The prey consisted of a random primed cDNA library prepared from CEMC7 cells (human T-cell line).
The bait construct comprised the C-terminal domain (aa341-507) of LEDGF/p75. Cell culture. HeLaP4 CCR5 cells, a kind gift from Pierre Charneau, Institut Pasteur, Paris, France, were grown in Dulbecco's modified Eagle's medium (DMEM) (Gibco-BRL, UK) supplemented with 10% fetal calf serum (FCS) (International Medical, Belgium), 20 µg/ml gentamicin (Gibco-BRL, UK) (further referred to as DMEM-complete) and 0.5 mg/ml geneticin at 37°C and 5% CO 2 in a humidified atmosphere. HelaP4 CCR5 Flag-LEDGF/p75 cells were treated the same with addition of 2 µg/ml HygromycinB (Invitrogen, UK) to the growth medium.
Expression plasmids and lentiviral vector cloning. pEGFP-pogZ was a kind gift from M. Lechner, Drexel university, Philadelphia, USA. A lentiviral vector construct for the expression of mRFP-∆NpogZ was produced by PCR amplification of the C-terminal coding region of pogZ from pEGFP-pogZ with the primers BamHI 5'-aatggatccatgttacccttgtctatgattgt and SalI 5'aatgtcgactcaaatctccatcagatc. The PCR product was digested and used to replace JPO2 in the pCHMWS-mRFP-JPO2-IRES-hygro transferplasmid (21), 3' to the mRFP-coding region. A bacterial expression plasmid encoding MBP-tagged C-terminal pogK, pK-∆N, was produced by PCR-amplification of pogK coding sequence from HelaP4 gDNA and insertion into pMalc2e (NEB, England) 3' to the MBP coding sequence. PCR primers used were F-EcoRI: 5'-aatgaattctatgaggtagctcagatgg, and R-BamHI: 5'-taaggatcctcagttgctctcagccatgc. The bacterial expression plasmid pZ-∆N was produced by PCR-amplification of the c-terminal coding region of pogZ from pEGFP-pogZ and cloning into pMalc2e 3' to the MBP-coding sequence. PCR primers used were F-EcoRI: 5'-aatgaattcatgttacccttgtctatgattgt, and R-BamHI: 5'-taaggatcctcaaatctccatcagatc. Bacterial expression plasmids encoding Flag-tagged LEDGF/p75 and its IBD mutants as well as bacterial expression plasmids encoding p52, LEDGF/p75, HIV-1 IN-His and MBP-JPO2 were described previously (21) . Eukaryotic expression plasmids and lentiviral vector constructs for the expression of mRFP-tagged LEDGF/p75, eGFP-tagged LEDGF/p75, and the NLS deficient mutant (K150A) as wel as eGFPtagged Δ325 and the D366A mutant were described previously (6, 9) . A lentiviral vector construct co-expressing Flag-tagged LEDGF/p75 and a hygromycin resistance gene was produced by PCR amplification of Flag-LEDGF/p75 from the Flag-LEDGF/p75 bacterial expression plasmid pCP-Nat-Flag (21) and cloning into pCHMWS-IRES-hygro transferplasmid, 5' to the IRES, yielding pCHMWS-Flag-LEDGF/p75 IRES-Hygro. Primers used were BglII F: gcgagatctatggactacaaagaccatgacg and SalI R : gaattcgtcgacctagttatctagtgtagaatcc.
Purification
of recombinant ∆NpogZ, LEDGF/p75, p52, HIV-1 integrase, CCD and ∆NpogK. pZ∆N and pK∆N were used to transform Rosetta2 E. coli cells (Novagen, Germany). The transformants were grown at 37°C to an OD 600 of 0.6 and protein production was induced by addition of 0.5 mM isopropylbeta-D-thiogalactopyranoside (IPTG). After induction the culture was allowed to grow for 4 h before cells were collected by centrifugation (15 min, 4°C, 6000 g). The bacterial pellet was resuspended in Lysis buffer (20 mM Tris/HCl pH 7.4, 200 mM NaCl) and lysed by sonication (MSE 150 Watt Ultrasonic Desintegrator). The MBP-∆NpogZ and MBP-∆NpogK fusion proteins were purified based on its affinity to Amylose-resin according to the manufacturer's protocol (New England Biolabs, UK). The protein concentration of the collected fractions was determined with a BCA test (Pierce, USA) and purity was determined by SDS-PAGE followed by coomassie brilliant blue staining (Sigma-Aldrich, USA). 20% Glycerol was added to the fractions with the highest concentration and purity. The respective protein samples were stored at -20°C. His-tagged HIV-1 IN was expressed from pRP1012 and purified as described previously (28) . Non-tagged LEDGF/p75 and p52 were expressed and purified as described previously (29) . The Flagtagged LEDGF/p75 expression and purification was essentially the same as for the non-tagged LEDGF/p75. HIV-1 IN CCD was purified as described previously (30) .
Vector production Lentiviral vectors were prepared as described previously (31) .
Stable cell lines
To make the HelaP4 CCR5 Flag-LEDGF/p75 stable cell line, HeLaP4 CCR5 cells were seeded in a 24-well plate and transduced with 10 4 RNA equivalents of CHMWS-Flag-LEDGF/p75 IRES-Hygro lentiviral vector the following day. After 4 h of incubation, the supernatant was removed, cells were washed with PBS, and 1 ml of DMEM complete medium was added. After 48 h, selection was initiated by adding 2 µg/ml HygromycinB (Invitrogen, UK).
Analysis of direct protein-protein interaction by AlphaScreen. The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux) and as described before (21) . Cross-titration experiments were performed by titrating increasing amounts of one protein interaction partner against different concentrations of a second protein interaction partner.
Co-immunoprecipitation (CoIP).
Nuclear extracts were prepared as described previously (32) and all further manipulations were performed at 4°C. ANTI-Flag® M2 Agarose Affinity beads (Sigma-Aldrich, Belgium) were washed with PBS and incubated with the lysate for 1 hour. The beads were collected by centrifugation (30 sec, 1800 g, 4 °C) and washed 3 times with 400 µl 400CSK buffer (10 mM Pipes pH 6.8, 10 % (w/v) sucrose, 1 mM DTT, 1 mM MgCl 2 , 400 mM NaCl, complete protease inhibitor w/o EDTA (Roche Molecular Biochemicals, Belgium). Immuno-precipitated protein was eluted with 40 µl SDS-PAGE loading buffer. Samples were analyzed by 10 % SDS-PAGE and Western blotting using appropriate antibodies.
Western blotting. Protein samples were separated on 10 % SDS PAGE and electroblotted onto polyvinylidene difluoride membranes (PVDF, Bio-Rad). Membranes were blocked with milk powder in PBS/0.1 % Tween20 and detection was carried out using mouse anti-LEDGF/p75 antibody (Bethyl, Montgomery TX), rabbit anti-pogZ antibody (Aviva Systems Biology, San Diego CA) or rabbit anti-mRFP antibody (Chemicon, Germany). Visualization was performed using chemiluminescence (ECL+, Amersham, UK) using anti-mouse (α-Flag) or anti-rabbit (α-pogZ, α-mRFP) antibodies coupled to HRP (Dako, Denmark).
Fluorescence and laser scanning microscopy. Cells grown in LabTek II glass chamber slides (VWR International) were fixed by incubation with 4% formaldehyde in PBS for 10 min and washed with PBS. The nuclear DNA was stained with 0.5 µg/ml Dapi (Molecular Probes).
Immunohistochemistry staining of pogZ was performed using anti-pogZ antibody (Aviva Systems Biology, San Diego, CA). Confocal microscopy was performed using an LSM 510 meta unit (Zeiss, Zaventem, Belgium). All images were acquired in the multi-track mode. eGFP was excited at 488 nm (AI laser), mRFP at 543 nm (HeNe laser), Dapi at 790 nm (MAI TAI two photon laser). After the main dichroic beam splitter (HFT UV/488/543/633 for eGFP, HFT 700/543 for mRFP and HFT KP 650 for dapi) the fluorescence signal was divided by a secondary dichroic beam splitter (NFT 490 for eGFP or NFT 545 for mRFP) and detected in the separate channels using the appropriate filters (BP 500550 for eGFP, BP 561-615 for mRFP and BP 435-485 for Dapi).
HIV infection and analysis of transfected HeLaP4 cells
The day prior to transient transfection 200,000 cells were seeded per well in a 6-well plate and attachment to the plate was allowed over night. Cells were transfected with 20 nM siRNA following the guidelines of the siFECTamin TM protocol. Synthetic siRNAs were designed as follows and provided by Qiagen (Belgium): sipZ1 (aagaagagagctgttaggaaa); sipZ2 (aaagaacagcgacagtacaaa); siCD-4 targeting the CD4 receptor was described previously (33) . Three days after transfection, 1.5 × 10 4 cells were re-seeded in a 24-well plate for 4 hrs at 37 °C. After attachment, cells were infected with 8.5 × 10 5 pg p24/ml of HIV-1 in a total volume of 250 µl. At 24 hrs after infection, a single well was analyzed for β -galactosidase activity (chemiluminescent β -Gal reporter gene assay; Roche Applied Science, Belgium). The β -galactosidase activity was measured according to the manufacturer's protocol. Chemiluminescence was measured with a LumiCount instrument (Packard, Belgium). The protein concentration of each sample was determined (BCA protein assay kit; Perbio), and read-outs were normalized for protein content.
Results

Identification of pogZ as a novel interaction partner of LEDGF/p75
In order to identify novel cellular interaction partners of LEDGF/p75 we performed a Y2H screen. In light of our ongoing drug discovery program, we were primarily interested in the identification of cellular binding partners of LEDGF/p75 that interact with the IBD. Therefore we used the C-terminal region (aa 341-507) as a bait ( Fig. 1.A) . The prey consisted of a CEM-C7 T-cell line cDNA library. Next to the earlier described LEDGF/p75 binding partner, JPO2 (21, 22) , the transposase-like protein, pogZ, was identified as putative interaction partner of LEDGF/p75. Ten clones of different length were identified and alignment of the sequences pinpointed to the C-terminal region of pogZ) as the specific interaction domain (SID) for LEDGF/ p75 ( Fig. 1.B) .
In silico analysis reveals pogZ to contain a DDE domain, a helix-turn-helix domain and a 6 zinc-finger array representing a domesticated DNA-transposase PogZ (Uniprot entry Q7Z3K3) was previously identified as a potential interaction partner of the transcription factor sp1 in a Y2H screen (34). However, nothing was known about the cellular function of the protein. PogZ (1410 aa) has a calculated Mw of 155 kDa. A sequence homology search using the NCBI-BLAST algorithm for the N-terminal region of pogZ showed 57% homology with the human protein ZNF280D overlapping the ZnF region ( Fig. 1.A) . A conserved domain scan using the NCBI BLAST algorithm (35) revealed the presence of a DDE domain and a DNA binding helix-turnhelix (HTH) domain in the C-terminal end of pogZ ( Fig. 1.B) . The specific interaction domain (SID) of pogZ with LEDGF/p75 overlapped with the predicted DDE domain ( Fig. 1.A and B) . This finding is of particular interest since the interaction of HIV-1 IN with LEDGF/p75 is mediated by the IN catalytic core domain (CCD), essentially a DDE domain (24, 36) . Next, the PSI-BLAST algorithm (37) was used to reveal functionally and evolutionarily important protein similarities for the DDE domain of pogZ (aa 1117-1323). When convergence was reached, PSI-BLAST uncovered sequence homology with Tigger derived (TIGD) transposases, such as TIGD1, human Jerky homologue (JRK) and human Jerky homologue like (JRKL) (Fig. 1.C) . Both Jerky and TIGD transposases are remnants of DNAtransposons related to the Tc1/mariner transposons that were active in the primate genome 60-80 million years ago (38, 39 ).
An earlier report points to the conservation of the catalytic D, D and D/E residues in the DDE domain of TIGD1 by sequence homology with Tc/mariner transposases (39) . Alignment of the human JRK, JRKL and TIGD1 with the DDE domain of pogZ demonstrates the conservation of the catalytic D, D and D/E residues in pogZ and both JRKL and JRK (Fig. 1.C) . The positioning of the catalytic residues in pogZ follows the D -D (35x) -D/E consensus. In addition, a search of the PDB repository for the closest enzymatically active, structural homologue of the pogZ DDE domain using the PHYRE search engine (40) yielded the DDE domain of mos-1 DNA-transposase (PDB entry: c2f7tA), which has a consensus DDE domain fold. Alignment of the predicted secondary structure of the DDE domains of pogZ and mos-1 revealed a significant conservation in length and position of secondary structure elements ( Fig. 1.D) . Although there is limited sequence homology at the primary structure, the catalytic important DDE/D triad of pogZ could be aligned with that of mos-1. Altogether, these data suggest that the pogZ protein represents a domesticated DNA transposase that was C-terminally fused to a ZnF rich domain. This hypothesis is further supported by the fact that the C-terminus of pogZ, including the transposase homology domain and the HTH (Fig. 1.A) is encoded by a single exon (exon 19) . A similar evolutionary path seems to be taken by a human paralogue of pogZ, pogK. Like pogZ and TIGDs, the C-terminal end of pogK also contains a predicted HTH and a DDE domain ( Fig. 1.A) . Similar to pogZ, this region is also encoded by a single exon for the pogK protein. In pogK, however, this transposase derived sequence is N-terminally fused to a predicted KRAB domain ( Fig. 1.A) . Sequence alignment of the DDE domain of pogK points to a loss of the Fig. 1.C) .
Confirmation of the cellular interaction between LEDGF/p75 and pogZ
Confocal fluorescence microscopy analysis of cells transiently transfected with a plasmid encoding eGFP-tagged pogZ demonstrated its specific nuclear localization. Whereas expression of the pogZ fusion was rather low (data not shown), co-expression of mRFP-tagged LEDGF/p75 resulted in increased eGFP-pogZ expression levels ( Fig. 2.A) . The fluorescent signals for eGFP-pogZ and mRFP-LEDGF/p75 displayed similar intranuclear localization (Fig.  2. A: overlay). To confirm that LEDGF/p75 and pogZ are in the same complex, HeLaP4 CCR5 cells stably overexpressing N-terminally Flag-tagged LEDGF/p75 (HeLaP4-CCR5 Flag-LEDGF/p75) were fractionated into a cytoplasmic, a soluble nuclear and an insoluble, high salt resistant chromatin fraction. Both pogZ and LEDGF/p75 were present in the nuclear fraction. Whereas LEDGF/p75 completely dissociated from the chromatin by applying 400 mM NaCl (Fig. 2 .B: compare lane 2 and 3 lower panel), a significant amount of pogZ remained associated with the chromatin (Fig. 2 .B: lane 2 and 3 upper panel) possibly due to a strong interaction of the 6-zinc finger array and the HTH domain with the chromatin. The soluble nuclear fraction was used for immunoprecipitation of Flag-tagged LEDGF/p75. Parental HeLaP4-CCR5 cells were used as control ( Fig. 2 .B: lane 6-7). Endogenous pogZ was efficiently co-immunoprecipitated with Flag-tagged LEDGF/p75 (Fig. 2.B) . Dilution of the 400 mM NaCl nuclear fraction to 250 mM NaCl improved pogZ coimmunoprecipitation ( Fig. 2 .B: compare lane 4 and 5 upper panel). These data indicate the presence of a salt-sensitive nuclear complex containing LEDGF/p75 and pogZ. In a separate set of co-immunoprecipitation experiments we could show that both pogZ and JPO2, alike HIV IN interact with Hrp2, next to LEDGF/p75 the only known human IBD containing protein (12) (Suppl. Fig. 1 ).
The pogZ-LEDGF/p75 interaction is mediated by the C-terminal domain of each protein
The Y2H data show an interaction between the pogZ DDE domain and the C-terminal part of LEDGF/p75. To verify this finding, colocalization of the fusion of mRFP to the Cterminal part of pogZ (mRFP-∆NpogZ) (aa 1117-1410, Fig. 1.A) with eGFP-LEDGF/p75 was evaluated by confocal microscopy. When expressed in the absence of eGFP-LEDGF/p75, mRFP-∆NpogZ showed an unspecific cellular distribution although a slight preference for the nucleus was observed (Fig. 3.A, upper panel) . Upon co-expression of eGFP-LEDGF/p75 and mRFP-∆NpogZ, the latter partially relocated to the nucleus (Fig. 3.A, middle panel) . Coexpression of mRFP-∆NpogZ and the NLSdefective mutant K150A mutant of eGFP-LEDGF/p75 excluded mRFP-∆NpogZ from the nucleus (Fig. 3.A, lower panel) as was previously shown for HIV- 1 IN (5,6,12 ). In addition, expression of mRFP-∆NpogZ in LEDGF/p75 knock-down cells resulted in lower mRFP∆NpogZ expression suggesting that LEDGF/p75 stabilizes mRFP-∆NpogZ (data not shown). In contrast the expression level of full length pogZ remained unaltered (data not shown). In an effort to narrow down the pogZ domain interacting with LEDGF/p75, the SID (see Figure 1 .B) of pogZ was fused to mRFP. However, we could not demonstrate a similar relocation upon coexpression with either eGFP-LEDGF/p75 or its NLS-deficient counterpart. This is possibly due to misfolding or sterical hindrance of the fluorescent protein tags (Fig. 3 .B: compare b to upper and middle panel of A). The interaction between LEDGF/p75 and the C-terminal end of pogZ was confirmed by co-immunoprecipitation of mRFP-∆NpogZ from HeLaP4 CCR5 Flag-LEDGF/p75 cells with anti-Flag agarose (Fig.  3 .C lane 2 lower panel). In this experiment total cell lysates were prepared in 400 mM NaCl and before co-immunoprecipitation diluted to 250 mM NaCl. Of note mRFP-∆NpogZ overexpression was able to partially outcompete endogenous pogZ for binding to LEDGF/p75 (Fig. 3 .C: compare lane 2 to 4 upper panel). We and others reported earlier that the Cterminal end of LEDGF/p75 (aa325-507, eGFP-Δ325) has a predominant nuclear localization and that co-expression of HIV-1 IN or the cellular LEDGF/p75 binding partner, JPO2, relocates both proteins to the cytoplasm (6, 21) . Likewise, mRFP-∆NpogZ and eGFP-Δ325 coexpression resulted in nuclear exclusion of both fusion proteins (Fig. 3.D) . In addition, it was previously shown that both JPO2 and IN specifically interact with the IBD domain of LEDGF/p75 (22) . Co-expression of an eGFP-IBD fusion together with mRFP-∆NpogZ also resulted in cytoplasmic relocalization indicating that the IBD is sufficient for the interaction with pogZ (data not shown). LEDGF/p75 is known to tether JPO2 and HIV-1 IN to the chromosomes during mitosis (22, 29) . To analyze whether LEDGF/p75 functions as a chromosome tethering factor for pogZ, the subcellular localization of endogenous pogZ during mitosis was analyzed by confocal microscopy in HelaP4 CCR5 cells (Fig. 4.A) . Surprisingly, pogZ did not associate with condensed chromatin. Overexpression of LEDGF/p75 as an eGFP-fusion localized to mitotic chromosomes without tethering mRFP∆NpogZ (Fig. 4.B) . These findings are at odds with the previous suggestion that LEDGF/p75 is a general chromatin tethering factor (22) . Next, the direct interaction between the LEDGF/p75 IBD and pogZ was studied in more detail using an AlphaScreen TM protein-protein interaction assay. The recombinant MBP-tagged C-terminus of pogZ (MBP-∆NpogZ) was purified from a bacterial lysate and direct interaction with recombinant Flag-tagged LEDGF/p75 (Flag-LEDGF/p75) was demonstrated in a cross-titration experiment (Fig. 5.A) . For all subsequent competition experiments equimolar amounts (100 nM) of MBP-∆NpogZ and Flag-LEDGF/p75 were chosen as baseline concentrations. Increasing amounts of recombinant non-tagged LEDGF/p75 and p52 were added to the interaction mixture containing 100 nM MBP-∆NpogZ and 100 nM Flag-LEDGF/p75. The recombinant LEDGF/p75 outcompeted the interaction while recombinant p52 did not (Fig. 5.B) . In addition, the Cterminus of the pogZ paralogue, pogK, was purified as a recombinant MBP-fusion protein.
However, this protein did not show interaction with Flag-tagged LEDGF/p75 in an AlphaScreen cross-titration interaction assay (data not shown). This experiment confirms the specificity of the LEDGF/p75-pogZ interaction, pinpointing the interaction site to the C-terminal domains of each protein.
The pogZ binding site in LEDGF/p75 overlaps to a larger extent with the HIV-1 IN binding site than does JPO2.
LEDGF/p75 interacts with the HIV-1 IN CCD (catalytic core domain) through its C-terminal IBD. A crystal structure of the IN CCD-IBD interaction was previously resolved and several amino acid residues crucial for the interaction with HIV-1 IN were identified (13, 41) . Although JPO2 also interacts with the IBD, our previous mutational analysis suggested that different contacts in the interface are required (21) . In the light of our ongoing drug discovery we are interested in the relative binding affinities of IBD cellular binding partners versus integrase. This research could also shed light on the mechanism by which IN outcompetes the cellular LEDGF/p75 interaction partners. Since pogZ also contains a DDE domain, we investigated whether amino acid residues in the IBD engaged by HIV-1 IN are also used by pogZ. Side-by-side comparison of the IBD mutants in the AlphaScreen assay revealed that neither the D366A nor V408A mutations affected the interaction with pogZ or JPO2, whereas they respectively abrogated and severely inhibited the interaction with HIV-1 IN (Fig. 6.A) . The K360A, I365A, V370A and F406A mutations on the other hand abrogated or severely inhibited the interaction of LEDGF/p75 with both pogZ and HIV-1 IN (Fig. 6.A) . As reported before, these mutations differentially affected interaction between LEDGF/p75 and JPO2 (21) (Fig. 6. A) These data demonstrate that binding of HIV-1 IN and pogZ to the IBD overlaps more than that of JPO2. (Fig. 6. A,B & C) .
PogZ does not restrict HIV-1 replication
Since HIV-1 IN and pogZ compete for an overlapping interaction site on LEDGF/p75 and since the interaction between LEDGF/p75 and HIV-1 integrase is of crucial importance for HIV-1 replication in the cell (7-9), we investigated whether the interaction with pogZ plays a role in HIV infection. An ELISA based assay (42) was performed to measure in vitro integrase activity in the presence of MBP-∆NpogZ. Biotin and digoxigenin-labeled oligonucleotides were incubated with recombinant HIV-1 integrase. As shown before (4), LEDGF/p75 stimulated integrase activity (Fig. 7.A) . In the absence or presence of LEDGF/p75, addition of increasing amounts of recombinant MBP-∆NpogZ did not affect integrase activity. This finding is in agreement with the finding that HIV-1 IN can efficiently outcompete pogZ for interaction with LEDGF/p75 (Fig. 6.B) . Next, we performed transient knock-down experiments to assess a possible role of pogZ in HIV-1 replication. HeLaP4 cells, containing an internal HIV-1 LTR driven β -galactosidase reporter gene, were transiently transfected with one of two different siRNAs targeting pogZ (sipZ1 and sipZ2) or mock transfected. As a positive control HeLaP4 cells were transiently transfected with with siRNA targeting the CD4 receptor (siCD-4). Knock-down of pogZ was monitored with Western Blotting (Fig. 7.B ). Cells were infected with a dilution series of HIV-1 NL4.3 for 24 hrs. After 24 hrs the cells were lysed and β -galactosidase reporter gene activity was determined (Fig. 7.C) . While an incomplete knock-down (sipZ2) induced a twofold stimulation, a near complete knock-down (sipZ1) of pogZ expression revealed wild type levels of HIV-1 replication compared with the mock-transfected control cells. These data are at odds with a major function of pogZ as a restriction factor of HIV-1 replication in this cell line.
Discussion
To gain more insight into the function of LEDGF/p75 in cell biology and during HIV replication, we embarked on the identification of cellular interaction partners. This knowledge is of crucial importance when considering the LEDGF/p75-HIV-1 IN interaction as an antiviral target. One aims at identifying small molecule inhibitors that block the interaction between IBD and HIV-1 IN without affecting the interaction of IBD with cellular binding partners. Alternatively, IBD binding partners could serve as restriction factors competing for the interaction with integrase.
Here we identified and validated pogZ as a novel cellular interaction partner of the IBD in LEDGF/p75. Our in silico analysis revealed that this protein with an unknown cellular function, shows striking homology to the DNAtransposase proteins of the TIGD family of which the domesticated CENP-B transposase is also a member (43) . PogZ features the hallmarks of a domesticated transposase that was Cterminally fused to a zinc finger-rich region. This hypothesis is strengthened by the fact that the entire C-terminal fragment of pogZ, containing the DDE domain and helix-turn-helix (HTH), is encoded by a single exon whereas the N-terminal part of the gene is encoded by multiple exons. The coding of the entire protein by an extensively spliced mRNA together with the large size of the entire gene and the absence of any obvious terminal inverted repeats indicate that the pogZ gene itself does not possess transposon activity. Domestication or the recruitment of transposase enzymes derived from mobile genetic elements into cellular functions has occurred multiple times in mammalian evolution. Well-known examples of such domesticated transposases function in nuclear organization (CENPB), recombination (RAG-1) or DNA-repair (SETmar) (44) . Via colocalization, co-immunoprecipitation and direct protein-protein interaction assays the interaction between LEDGF/p75 and pogZ was validated. We showed that the interaction is mediated by the IBD of LEDGF/p75. The IBD interacts with the C-terminus of pogZ which includes the transposase-derived DDE domain. This finding is of particular interest given that HIV-1 integrase also interacts with the LEDGF/p75 IBD through its DDE-domain containing CCD (13, 45) . In contrast to JPO2, HIV-1 integrase and pogZ show a significant overlap in critical IBD amino acid residues required for interaction. IBD mutations I365A, V370A and F406A equally affected the interactions with HIV-1 IN and pogZ. On the contrary, mutations D366A and V408A had no effect on the interaction between LEDGF/p75 and pogZ whereas these mutants abrogate the interaction of LEDGF/p75 with HIV-1 IN. Possibly these residues enable integrase to outcompete JPO2 and pogZ for binding to LEDGF/p75, a crucial property that assures hijacking of LEDGF/p75 by the HIV PIC and consecutive targeting of the virus to the cellular genome (Fig. 6.A) . As JPO2 and pogZ have a comparable affinity for LEDGF/p75, the more efficient and complete outcompetition of the pogZ-LEDGF/p75 interaction by the HIV-1 IN CCD as compared to the JPO2-LEDGF/p75 interaction further corroborates the extensive overlap in IBD residues engaged by both HIV- 1  IN and pogZ (Fig. 6.B) . Elucidation of the structural basis of the differential interactions of the LEDGF/p75 binding proteins with the IBD should confirm this hypothesis. Recently the MLL methyltransferase was shown to be yet another IBD interacting protein (20) . Interestingly, a third player, menin, is required for this interaction. This requirement may explain why MLL was not highlighted by our Y2H screen. Given the essential importance of the LEDGF/p75-MLL interaction in leukemogenesis (20) it is mandatory to incorporate MLL in future interaction studies. Together these findings suggest that the Cterminus of LEDGF acts as a playground for protein-protein interaction. Side by side comparison of the positioning of the catalytic triad DDE/D amino acid residues in the DDE domain of TIGD1 with those in the DDE domain of the pogZ protein reveals the conservation of these residues. Identification of a putative catalytic activity in a nucleic acid modifying pathway mediated by pogZ would shed more light on the cellular functions of both LEDGF/p75 and pogZ. The DDE domain of pogK, the human paralogue of pogZ, does not appear to contain these conserved catalytic DDE/D residues. Interestingly, we could not detect an interaction between LEDGF/p75 and pogK (data not shown). Next to a better understanding of the function of LEDGF/p75 in cellular pathways and viral replication this study has also important implications for future anti-HIV drug development. Subsequent to the validation of LEDGF/p75 as an important HIV-1 cofactor drug discovery labs in academia and industry now exploit the IN-LEDGF/p75 interaction as a new antiviral target (46) (47) (48) . In the light of cellular toxicity the effect of potential drugs on pogZ and JPO2 binding to LEDGF/p75 should be assessed. The fact that the binding mode of JPO2 and pogZ to LEDGF/p75 does not entirely overlap with the binding of IN to LEDGF/p75 supports the feasibility of specific drug design. Because LEDGF/p75 links both JPO2 and HIV-1 IN to chromatin (22, 29) , LEDGF/p75 has been described as a multifunctional tethering factor. Our finding that pogZ nor the C-terminal part of pogZ associate with mitotic chromosomes, even when LEDGF/p75 is overexpressed (Fig. 4) , indicates that this function of LEDGF/p75 is not applicable to pogZ. Since pogZ and integrase bind to the same domain of LEDGF/p75, pogZ might potentially act as a restriction factor to viral replication. The well known stimulation of in vitro integrase activity by LEDGF/p75 however was not inhibited by the addition of MBP-∆NpogZ. Accordingly, transient knockdown of pogZ, showed either no or only a two-fold stimulation of HIV-1 replication in HeLaP4 cells. These findings indicate no important function for the LEDGF/p75-pogZ interaction in HIV-1 replication but further point to a mechanism whereby HIV-1 IN usurps LEDGF/p75 in the cell during infection. Binding of LEDGF/p75 to integrases is lentiviral specific (2, 4) . The finding that LEDGF/p75 can bind a domesticated transposase sheds a new light on this finding. Possibly a common ancestor was able to interact with LEDGF/p75 while this interaction was lost in most retroviruses and transposons. An evolutionary link between the DDE domains of Tc/Mariner DNA transposases, retrotransposons and retroviruses through a common ancestor has been suggested previously (49,50). Alternatively, LEDGF/p75 interaction might have occurred several times in a convergent evolution. In any case binding of LEDGF/p75 to a DDE domain containing protein must have significant functional advantage. Given that the DDE domain of pogZ shows an evolutionary link with the DDE domains of Tc1/Mariner DNA transposases through its homology with TIGD transposases, we are currently investigating the possible involvement of LEDGF/p75 in the interaction and functionality of DDE domains of other genetic mobile elements such as human DNA transposons. 5) and HeLaP4 CCR5 cells (lane 6-7) were fractionated into a cytoplasmic (lane 1), a nuclear (lane 2) and a chromatin associated fraction (lane 3). Co-immunoprecipitation was performed on the nuclear fraction in 400 mM NaCl (lanes 4-6) or 250 mM NaCl (lanes 5-7) using Flag-M2-agarose resin to immunoprecipitate the Flag-tagged LEDGF/p75. Samples were separated by SDS-PAGE followed by western blotting. The presence of pogZ and LEDGF/p75 in the samples was verified using anti-pogZ (upper panel) or anti-LEDGF/p75 (lower panel) antibodies, respectively. 3-4) . Total cell lysate was prepared in 400 mM NaCl to remove LEDGF/p75 from the chromatin and subsequently diluted to 250 mM NaCl to perform the immunoprecipitation using Flag-M2 agarose resin. Samples were run in a SDS-PAGE gel followed by western blotting. The presence of mRFP-∆NpogZ, endogenous pogZ and LEDGF/p75 in the samples was analyzed 
